Explain Why Patients Shouldn't Wait to Get Shingrix Instead of Zostavax
There's buzz about a new zoster vaccine in the pipeline that's tentatively called Shingrix (SHING-riks).
It probably won't be approved until late 2017 at best.
But it's already making headlines...because it seems to work better than Zostavax to prevent shingles.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote